scholarly article | Q13442814 |
P2093 | author name string | I D B Marques | |
L P F Carmo | |||
V A H Sato | |||
V Woronik | |||
L B Jorge | |||
P T Goldenstein | |||
R T Barros | |||
S M O Titan | |||
P2860 | cites work | The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents | Q22305963 |
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Update on pediatric systemic lupus erythematosus | Q33340316 | ||
The classification of glomerulonephritis in systemic lupus erythematosus revisited | Q34293066 | ||
Lupus nephritis in childhood: a review of 53 patients followed at a single center | Q35591764 | ||
Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literature | Q35938845 | ||
Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices | Q36252528 | ||
Late onset systemic lupus erythematosus | Q39546725 | ||
Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS). | Q42638034 | ||
Severe paediatric systemic lupus erythematosus nephritis--a single-centre experience | Q43276371 | ||
The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese | Q45166241 | ||
Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome | Q46262236 | ||
Renal damage in systemic lupus erythematosus: a comparative analysis of different age groups. | Q53242137 | ||
P433 | issue | 9 | |
P921 | main subject | teenager | Q1492760 |
lupus nephritis | Q1621830 | ||
P304 | page(s) | 978-983 | |
P577 | publication date | 2012-03-26 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Lupus nephritis is more severe in children and adolescents than in older adults. | |
P478 | volume | 21 |
Q39178596 | Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus |
Q36375184 | Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis |
Q22299246 | Associations of clinical features and prognosis with age at disease onset in patients with systemic lupus erythematosus |
Q51196776 | Children and adolescents with SLE: not just little adults. |
Q41317956 | Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE. |
Q91915703 | Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis |
Q92615904 | Comparison of Clinical and Laboratory Findings in Patients with Systemic Lupus Erythematosus with Regard to Age at Onset |
Q38819070 | Comparison of clinical, serological, and prognostic differences among juvenile-, adult-, and late-onset lupus nephritis in Korean patients |
Q33431990 | Differences in disease phenotype and severity in SLE across age groups |
Q40505162 | Juvenile systemic lupus erythematosus in Nigeria |
Q40857973 | Long-term renal outcomes of childhood-onset global and segmental diffuse proliferative lupus nephritis |
Q89548147 | Mast cells in the kidney biopsies of pediatric patients with lupus nephritis |
Q37328887 | Serum IL-18 as biomarker in predicting long-term renal outcome among pediatric-onset systemic lupus erythematosus patients. |
Q91915080 | The impact of antiphospholipid antibodies in children with lupus nephritis |
Q51300605 | Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study. |
Q39160729 | Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy. |
Q37690103 | Update on differences between childhood-onset and adult-onset systemic lupus erythematosus |
Search more.